VIP and coronary artery disorder: Figure 3B illustrates that VIP levels in the CMD group were significantly lower than in the CMM group (p < 0.05) and also lower than in the CLD and CHD groups (p < 0.01). In Figure 3C, a decrease in AQP3 levels was observed in the CMM group.